lazurite dermaceuticals ltd
lazurite dermaceuticals ltd Company Information
Company Number
13469217
Next Accounts
Mar 2025
Industry
Manufacture of basic pharmaceutical products
Shareholders
yasmin mahmmod
samer taslaq
Group Structure
View All
Contact
Registered Address
11 bridgegate centre, welwyn garden city, AL7 1JG
Website
-lazurite dermaceuticals ltd Estimated Valuation
Pomanda estimates the enterprise value of LAZURITE DERMACEUTICALS LTD at £75.2k based on a Turnover of £72.5k and 1.04x industry multiple (adjusted for size and gross margin).
lazurite dermaceuticals ltd Estimated Valuation
Pomanda estimates the enterprise value of LAZURITE DERMACEUTICALS LTD at £0 based on an EBITDA of £-606 and a 4.1x industry multiple (adjusted for size and gross margin).
lazurite dermaceuticals ltd Estimated Valuation
Pomanda estimates the enterprise value of LAZURITE DERMACEUTICALS LTD at £0 based on Net Assets of £-2.3k and 1.81x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Lazurite Dermaceuticals Ltd Overview
Lazurite Dermaceuticals Ltd is a live company located in welwyn garden city, AL7 1JG with a Companies House number of 13469217. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in June 2021, it's largest shareholder is yasmin mahmmod with a 50% stake. Lazurite Dermaceuticals Ltd is a startup, micro sized company, Pomanda has estimated its turnover at £72.5k with unknown growth in recent years.
Upgrade for unlimited company reports & a free credit check
Lazurite Dermaceuticals Ltd Health Check
Pomanda's financial health check has awarded Lazurite Dermaceuticals Ltd a 1 rating. We use a traffic light system to show it exceeds the industry average on 1 measures and has 6 areas for improvement. Company Health Check FAQs
1 Strong
1 Regular
6 Weak
Size
annual sales of £72.5k, make it smaller than the average company (£33.4m)
- Lazurite Dermaceuticals Ltd
£33.4m - Industry AVG
Growth
There is insufficient data available for this Key Performance Indicator!
- Lazurite Dermaceuticals Ltd
- - Industry AVG
Production
with a gross margin of 20%, this company has a higher cost of product (37.7%)
- Lazurite Dermaceuticals Ltd
37.7% - Industry AVG
Profitability
an operating margin of -0.8% make it less profitable than the average company (6.8%)
- Lazurite Dermaceuticals Ltd
6.8% - Industry AVG
Employees
with 1 employees, this is below the industry average (113)
1 - Lazurite Dermaceuticals Ltd
113 - Industry AVG
Pay Structure
on an average salary of £60.6k, the company has an equivalent pay structure (£60.6k)
- Lazurite Dermaceuticals Ltd
£60.6k - Industry AVG
Efficiency
resulting in sales per employee of £72.5k, this is less efficient (£403.8k)
- Lazurite Dermaceuticals Ltd
£403.8k - Industry AVG
Debtor Days
it gets paid by customers after 2 days, this is earlier than average (58 days)
- Lazurite Dermaceuticals Ltd
58 days - Industry AVG
Creditor Days
There is insufficient data available for this Key Performance Indicator!
- Lazurite Dermaceuticals Ltd
- - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Lazurite Dermaceuticals Ltd
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Lazurite Dermaceuticals Ltd
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 496.5%, this is a higher level of debt than the average (46.8%)
496.5% - Lazurite Dermaceuticals Ltd
46.8% - Industry AVG
LAZURITE DERMACEUTICALS LTD financials
Lazurite Dermaceuticals Ltd's latest turnover from June 2023 is estimated at £72.5 thousand and the company has net assets of -£2.3 thousand. According to their latest financial statements, Lazurite Dermaceuticals Ltd has 1 employee and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jun 2023 | Jun 2022 | |
|---|---|---|
| Turnover | ||
| Other Income Or Grants | ||
| Cost Of Sales | ||
| Gross Profit | ||
| Admin Expenses | ||
| Operating Profit | ||
| Interest Payable | ||
| Interest Receivable | ||
| Pre-Tax Profit | ||
| Tax | ||
| Profit After Tax | ||
| Dividends Paid | ||
| Retained Profit | ||
| Employee Costs | ||
| Number Of Employees | 1 | 1 |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jun 2023 | Jun 2022 | |
|---|---|---|
| Tangible Assets | 0 | 0 |
| Intangible Assets | 0 | 0 |
| Investments & Other | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 |
| Total Fixed Assets | 0 | 0 |
| Stock & work in progress | 0 | 0 |
| Trade Debtors | 570 | 138 |
| Group Debtors | 0 | 0 |
| Misc Debtors | 0 | 0 |
| Cash | 0 | 0 |
| misc current assets | 0 | 0 |
| total current assets | 570 | 138 |
| total assets | 570 | 138 |
| Bank overdraft | 0 | 0 |
| Bank loan | 0 | 0 |
| Trade Creditors | 0 | 0 |
| Group/Directors Accounts | 0 | 0 |
| other short term finances | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| other current liabilities | 0 | 0 |
| total current liabilities | 0 | 0 |
| loans | 0 | 0 |
| hp & lease commitments | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 |
| other liabilities | 2,830 | 1,792 |
| provisions | 0 | 0 |
| total long term liabilities | 2,830 | 1,792 |
| total liabilities | 2,830 | 1,792 |
| net assets | -2,260 | -1,654 |
| total shareholders funds | -2,260 | -1,654 |
| Jun 2023 | Jun 2022 | |
|---|---|---|
| Operating Activities | ||
| Operating Profit | ||
| Depreciation | 0 | 0 |
| Amortisation | 0 | 0 |
| Tax | ||
| Stock | 0 | 0 |
| Debtors | 432 | 138 |
| Creditors | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 |
| Cash flow from operations | ||
| Investing Activities | ||
| capital expenditure | ||
| Change in Investments | 0 | 0 |
| cash flow from investments | ||
| Financing Activities | ||
| Bank loans | 0 | 0 |
| Group/Directors Accounts | 0 | 0 |
| Other Short Term Loans | 0 | 0 |
| Long term loans | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 |
| other long term liabilities | 1,038 | 1,792 |
| share issue | ||
| interest | ||
| cash flow from financing | ||
| cash and cash equivalents | ||
| cash | 0 | 0 |
| overdraft | 0 | 0 |
| change in cash | 0 | 0 |
lazurite dermaceuticals ltd Credit Report and Business Information
Lazurite Dermaceuticals Ltd Competitor Analysis
Perform a competitor analysis for lazurite dermaceuticals ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in AL7 area or any other competitors across 12 key performance metrics.
lazurite dermaceuticals ltd Ownership
LAZURITE DERMACEUTICALS LTD group structure
Lazurite Dermaceuticals Ltd has no subsidiary companies.
Ultimate parent company
LAZURITE DERMACEUTICALS LTD
13469217
lazurite dermaceuticals ltd directors
Lazurite Dermaceuticals Ltd currently has 2 directors. The longest serving directors include Ms Yasmin Mahmmod (Jun 2021) and Dr Samer Taslaq (Jun 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Yasmin Mahmmod | England | 38 years | Jun 2021 | - | Director |
| Dr Samer Taslaq | United Kingdom | 44 years | Jun 2023 | - | Director |
P&L
June 2023turnover
72.5k
+2%
operating profit
-606
0%
gross margin
20%
-8.82%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2023net assets
-2.3k
+0.37%
total assets
570
+3.13%
cash
0
0%
net assets
Total assets minus all liabilities
Similar Companies
lazurite dermaceuticals ltd company details
company number
13469217
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
June 2021
age
4
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
June 2023
previous names
N/A
accountant
-
auditor
-
address
11 bridgegate centre, welwyn garden city, AL7 1JG
Bank
-
Legal Advisor
-
lazurite dermaceuticals ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to lazurite dermaceuticals ltd.
lazurite dermaceuticals ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LAZURITE DERMACEUTICALS LTD. This can take several minutes, an email will notify you when this has completed.
lazurite dermaceuticals ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
